Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

Garber AJ;King AB;Del Prato S;Sreenan S;Balci MK;Muñoz Torres M;Rosenstock J;Endahl LA;Francisco AM;Hollander P;Protich M;Ivanov V;Veleva N;Pichmanova M;Guerenova J;Hristozov K;Slavcheva A;Petrova Gancheva;Prakova Teneva Z;Böhmer M;Clever HU;Kaiser M;Peter Kempe H;Mölle A;Paulus R;Rose L;Sauter J;Kinsley B;Nolan J;Sreenan S;Hayes F;Joshi P;Khutsoane DT;Reddy J;Mayet L;Burgess LJ;Raya PM;Cros MR;Calle A;Candil SD;Soto A;Francisco J;Torres M;Dominguez JR;Mesa J;Mur AL;Muñoz Torres M;Del Prato S;Filetti S;Piatti P;Vespasiani G;Santeusanio F;Fanelli CG;Mannucci E;Consoli A;Pata P;CIGNARELLI, MAURO;Borzì V;Trevisan R;Serban V;Catrinoiu D;Creteanu G;Pop L;Coman A;Dogadin S;Dvoryashina I;Karpova I;Lysenko T;Smirnova E;Yakusevich V;Fábry J;Ilavská A;Tomášová L;Tošerová E;Chow FC;Karsidag K;Erguney M;Akbay E;Balçi MK;Anderson C;Baker C;Berbano R;Blevins T;Broadstone V;Brody M;Brunner J;Brusco O;Case C;Cherlin R;Chuck L;Clower J;Connor G;Cooperman M;Paysinger A;Early M;Elliott S;Fitz Patrick D;Furlong K;Garber A;Glaser L;Albert S;Griffing G;Handke L;Harris R;Hermayer K;Hollander P;Huntley R;Kaye W;Kennedy J;King A;Klein E;Lipetz R;Snell P;Morawski E;Nurnberg R;Orr R;Osei K;Palace E;Raad G;Rasmussen B;Reeves M;Roberts V;Rodbard H;Rosenblit P;Rosenstock J;Selam JL;Shaw S;Shelmet J;Simon H;Smith M;Stringam S;Sussman A;Testa J;Mazza A;Varano S;Warren M;Winkle P;Wise J;Aroda V;Strzinek R;Wong M;Pollock J;Bode B.

2012-01-01